Concepedia
Statistics
Publications
11
Citations
437
H-Index
Active since
1994
Affiliations
UCB Pharma (United Kingdom)(Current)
Centre National de la Recherche Scientifique
Inserm
NIHR Birmingham Biomedical Research Centre
University of Birmingham
Andrew Payne is an author at UCB Pharma (United Kingdom) specializing in immunology, pharmacology, and life sciences.
Publications per year
1994–2020
Tetrahydroisoquinoline amide substituted phenyl pyrazoles as selective Bcl-2 inhibitors
John Porter, Andrew Payne, Ben de Candole et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 123 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +9
A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren’s syndrome
Maria Juárez, Nieves Díaz, Geoffrey I. Johnston et al. · Lara D. Veeken · 2020 · 48 citations · Full text
Medicine, Immunology, Immunopharmacotherapy +13
Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren's syndrome
Saba Nayar, Joana Campos, Charlotte G. Smith et al. · Annals of the Rheumatic Diseases · 2018 · 45 citations · Full text
Life Sciences, Immunology, Pathology +17
Seletalisib: Characterization of a Novel, Potent, and Selective Inhibitor of PI3Kδ
Rodger A. Allen, Daniel C. Brookings, Mark Powell et al. · Journal of Pharmacology and Experimental Therapeutics · 2017 · 44 citations
Life Sciences, Immunology, Pharmacology +16
Selective targeting of PI3Kδ suppresses human IL-17-producing T cells and innate-like lymphocytes and may be therapeutic for IL-17-mediated diseases
Sijia Chen, Ross A. Paveley, Lianne Kraal et al. · Journal of Autoimmunity · 2020 · 35 citations · Full text
Life Sciences, Cell Biology, Immunology +17
1–5 of 11